Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Michael Adam Fischer, M.D.

TitleAssociate Professor of Medicine
InstitutionBrigham and Women's Hospital
DepartmentMedicine
AddressBrigham and Women's Hospital -
General Medicine - Suite 3030
1620 Tremont St
Boston MA 02120
Phone617/278-0930
Fax617/232-8602

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Shrank WH, Choudhry NK, Agnew-Blais J, Federman AD, Liberman JN, Liu J, Kesselheim AS, Brookhart MA, Fischer MA. State generic substitution laws can lower drug outlays under Medicaid. Health Aff (Millwood). 2010 Jul; 29(7):1383-90.
    View in: PubMed
  2. Zhang Y, Lave JR, Donohue JM, Fischer MA, Chernew ME, Newhouse JP. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Med Care. 2010 May; 48(5):409-17.
    View in: PubMed
  3. Chan DC, Shrank WH, Cutler D, Jan S, Fischer MA, Liu J, Avorn J, Solomon D, Brookhart MA, Choudhry NK. Patient, physician, and payment predictors of statin adherence. Med Care. 2010 Mar; 48(3):196-202.
    View in: PubMed
  4. Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, Weissman JS. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010 Apr; 25(4):284-90.
    View in: PubMed
  5. Shrank WH, Cox ER, Fischer MA, Mehta J, Choudhry NK. Patients' perceptions of generic medications. Health Aff (Millwood). 2009 Mar-Apr; 28(2):546-56.
    View in: PubMed
  6. Shrank WH, Cadarette SM, Cox E, Fischer MA, Mehta J, Brookhart AM, Avorn J, Choudhry NK. Is there a relationship between patient beliefs or communication about generic drugs and medication utilization? Med Care. 2009 Mar; 47(3):319-25.
    View in: PubMed
  7. Fischer MA, Vogeli C, Stedman M, Ferris T, Brookhart MA, Weissman JS. Effect of electronic prescribing with formulary decision support on medication use and cost. Arch Intern Med. 2008 Dec 8; 168(22):2433-9.
    View in: PubMed
  8. Fischer MA, Polinski JM, Servi AD, Agnew-Blais J, Kaci L, Solomon DH. Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid programs. Arthritis Rheum. 2008 Nov 15; 59(11):1611-7.
    View in: PubMed
  9. Fischer MA, Vogeli C, Stedman MR, Ferris TG, Weissman JS. Uptake of electronic prescribing in community-based practices. J Gen Intern Med. 2008 Apr; 23(4):358-63.
    View in: PubMed
  10. Shrank WH, Stedman M, Ettner SL, DeLapp D, Dirstine J, Brookhart MA, Fischer MA, Avorn J, Asch SM. Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use. J Gen Intern Med. 2007 Sep; 22(9):1298-304.
    View in: PubMed
  11. Fischer MA, Choudhry NK, Winkelmayer WC. Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing? Health Aff (Millwood). 2007 May-Jun; 26(3):800-7.
    View in: PubMed
  12. Polinski JM, Wang PS, Fischer MA. Medicaid's prior authorization program and access to atypical antipsychotic medications. Health Aff (Millwood). 2007 May-Jun; 26(3):750-60.
    View in: PubMed
  13. Fischer MA, Morris CA, Winkelmayer WC, Avorn J. Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients. Arch Intern Med. 2007 Apr 23; 167(8):840-6.
    View in: PubMed
  14. Qureshi A, Fischer MA. Topical calcineurin inhibitors revisited. Arch Dermatol. 2007 Apr; 143(4):545-6.
    View in: PubMed
  15. Patrick AR, Winkelmayer WC, Avorn J, Fischer MA. Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysis. Pharmacoeconomics. 2007; 25(11):949-61.
    View in: PubMed
  16. Fischer MA. The National e-Prescribing Patient Safety Initiative: removing one hurdle, confronting others. Drug Saf. 2007; 30(6):461-4.
    View in: PubMed
  17. Fischer MA, Servi AD, Polinski JM, Wang PS. Restrictions on antidepressant medications for children: a review of Medicaid policy. Psychiatr Serv. 2007 Jan; 58(1):135-8.
    View in: PubMed
  18. Winkelmayer WC, Fischer MA, Schneeweiss S, Levin R, Avorn J. Angiotensin inhibition after myocardial infarction: does drug class matter? J Gen Intern Med. 2006 Dec; 21(12):1242-7.
    View in: PubMed
  19. Kesselheim AS, Fischer MA, Avorn J. Extensions of intellectual property rights and delayed adoption of generic drugs: effects on medicaid spending. Health Aff (Millwood). 2006 Nov-Dec; 25(6):1637-47.
    View in: PubMed
  20. Kesselheim AS, Fischer MA, Avorn J. The rise and fall of Natrecor for congestive heart failure: implications for drug policy. Health Aff (Millwood). 2006 Jul-Aug; 25(4):1095-102.
    View in: PubMed
  21. Fischer MA, Cheng H, Schneeweiss S, Avorn J, Solomon DH. Prior authorization policies for selective cyclooxygenase-2 inhibitors in Medicaid: a policy review. Med Care. 2006 Jul; 44(7):658-63.
    View in: PubMed
  22. Udell JA, Fischer MA, Brookhart MA, Solomon DH, Choudhry NK. Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid. J Bone Miner Res. 2006 May; 21(5):765-71.
    View in: PubMed
  23. Qureshi AA, Fischer MA. Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risks. Arch Dermatol. 2006 May; 142(5):633-7.
    View in: PubMed
  24. Fischer MA, Avorn J. Educating trainees about the cost of medications. Virtual Mentor. Available at http://www.ama-assn.org/ama/pub/category/15953.html. 2006; 8:142-6.
  25. Winkelmayer WC, Fischer MA, Schneeweiss S, Wang PS, Levin R, Avorn J. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis. 2005 Dec; 46(6):1080-7.
    View in: PubMed
  26. Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, Brookhart MA. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005 Dec 1; 353(22):2335-41.
    View in: PubMed
  27. Wang PS, Avorn J, Brookhart MA, Mogun H, Schneeweiss S, Fischer MA, Glynn RJ. Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension. 2005 Aug; 46(2):273-9.
    View in: PubMed
  28. Fischer MA, Winkelmayer WC, Rubin RH, Avorn J. The hepatotoxicity of antifungal medications in bone marrow transplant recipients. Clin Infect Dis. 2005 Aug 1; 41(3):301-7.
    View in: PubMed
  29. Fischer MA, Schneeweiss S, Avorn J, Solomon DH. Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors. N Engl J Med. 2004 Nov 18; 351(21):2187-94.
    View in: PubMed
  30. Fischer MA, Avorn J. Economic implications of evidence-based prescribing for hypertension: can better care cost less? JAMA. 2004 Apr 21; 291(15):1850-6.
    View in: PubMed
  31. Fischer MA, Avorn J. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit. Pharmacoepidemiol Drug Saf. 2004 Apr; 13(4):207-14.
    View in: PubMed
  32. Fischer MA, Lilly CM, Churchill WW, Baden LR, Avorn J. An algorithmic computerised order entry approach to assist in the prescribing of new therapeutic agents: case study of activated protein C at an academic medical centre. Drug Saf. 2004; 27(15):1253-61.
    View in: PubMed
  33. Fischer MA, Solomon DH, Teich JM, Avorn J. Conversion from intravenous to oral medications: assessment of a computerized intervention for hospitalized patients. Arch Intern Med. 2003 Nov 24; 163(21):2585-9.
    View in: PubMed
  34. Fischer MA, Avorn J. Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans. Health Serv Res. 2003 Aug; 38(4):1051-63.
    View in: PubMed
  35. Amaravadi RK, Jacobson BC, Solomon DH, Fischer MA. Acute pancreatitis associated with rofecoxib. Am J Gastroenterol. 2002 Apr; 97(4):1077-8.
    View in: PubMed
  36. Fischer MA. Excess sample size and the ’Delta Wobble’ in randomized controlled trials. 1997.
  37. Fischer MA, Feinstein AR. The etymology and pathogenesis of "wonk". J Clin Epidemiol. 1995 Aug; 48(8):1089-90.
    View in: PubMed
  38. Currie J, Gruber J, Fischer M. Physician payment and infant mortality: evidence from Medicaid fee policy. American Economic Review Papers and Proceedings. 1995; 82(2):106-11.
  39. Fischer MA. Weighing the evidence: an empirical analysis of the expansions of Medicaid coverage for pregnant women, 1984-1990. 1992.
  40. Winickoff RN, Fischer MA, August BJ. Appropriateness of short-stay admissions for procedures in six Veterans Affairs hospitals. QRB Qual Rev Bull. 1991 Dec; 17(12):386-91.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Fischer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
See all (226) concept(s)
_
Co-Authors
See all (20) people
_
Similar People
See all (60) people
_
Same Department
Search Department
Physical Neighbors
_